Cargando…

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Fe(III) complexes have again attracted much attention for application as MRI contrast agents in recent years due to their high thermodynamic stability, low long-term toxicity, and large relaxivity at a higher magnetic field. This mini-review covers the recent progress on low-molecular-weight Fe(III)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shangjun, An, Lu, Yang, Shiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324404/ https://www.ncbi.nlm.nih.gov/pubmed/35889445 http://dx.doi.org/10.3390/molecules27144573

Ejemplares similares

Defining the conditions for the development of the emerging class of Fe(III)-based MRI contrast agents
por: Baranyai, Zsolt, et al.
Publicado: (2021)

Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups
por: Asik, Didar, et al.
Publicado: (2020)

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
por: Chen, Zhijin, et al.
Publicado: (2009)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Fe Doped Magnetic Nanodiamonds Made by Ion Implantation as Contrast Agent for MRI
por: Lin, Bo-Rong, et al.
Publicado: (2018)

Fabrication of Fe(III)-doped mesoporous silica nanoparticles as biocompatible and biodegradable theranostic system for Remdesivir delivery and MRI contrast agent
por: Arkaban, Hasan, et al.
Publicado: (2023)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2008)

A Peptide Targeted Contrast Agent Specific to Fibrin−Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2009)

Iron(iii) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T(1)-weighted MRI contrast agent
por: Marasini, Ramesh, et al.
Publicado: (2021)

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents
por: Silva, Simone Rodrigues, et al.
Publicado: (2015)

Mn-Based MRI Contrast Agents: An Overview
por: Henoumont, Céline, et al.
Publicado: (2023)

Iron Oxide as an MRI Contrast Agent for Cell Tracking
por: Korchinski, Daniel J., et al.
Publicado: (2015)

Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T(2) MRI contrast agents
por: Kuźnik, Nikodem, et al.
Publicado: (2015)

Gadonanotubes as new high-performance MRI contrast agents
por: Sitharaman, Balaji, et al.
Publicado: (2006)

Multiwalled carbon nanotube hybrids as MRI contrast agents
por: Kuźnik, Nikodem, et al.
Publicado: (2016)

Ellagic acid-Fe@BSA nanoparticles for endogenous H(2)S accelerated Fe(III)/Fe(II) conversion and photothermal synergistically enhanced chemodynamic therapy
por: Tian, Qingqing, et al.
Publicado: (2020)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

Low-molecular-weight paramagnetic (19)F contrast agents for fluorine magnetic resonance imaging
por: Herynek, Vít, et al.
Publicado: (2018)

Macromolecules with Different Charges, Lengths, and Coordination Groups for the Coprecipitation Synthesis of Magnetic Iron Oxide Nanoparticles as T(1) MRI Contrast Agents
por: Tao, Cheng, et al.
Publicado: (2019)

Fe/Mn Multilayer Nanowires as High-Performance T(1)-T(2) Dual Modal MRI Contrast Agents
por: Cao, Xiaoming, et al.
Publicado: (2021)

Holmium(III) Single-Ion Magnet for Cryomagnetic Refrigeration Based on an MRI Contrast Agent Derivative
por: Rodríguez-Barea, Borja, et al.
Publicado: (2021)

Polymerizable Gd(iii) building blocks for the synthesis of high relaxivity macromolecular MRI contrast agents
por: Berki, Thomas R., et al.
Publicado: (2021)

Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents
por: Lu, Zheng-Rong, et al.
Publicado: (2006)

Study of Complexes of Tannic Acid with Fe(III) and Fe(II)
por: Fu, Zhaofeng, et al.
Publicado: (2019)

Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications
por: Chen, Weipeng, et al.
Publicado: (2023)

Modeling Gd(3+) Complexes for Molecular Dynamics Simulations: Toward a Rational Optimization of MRI Contrast Agents
por: Oliveira, Alexandre C., et al.
Publicado: (2022)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Water-soluble l-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma
por: Liang, Shuyan, et al.
Publicado: (2015)

Structure-Activity Relationship for Fe(III)-Salen-Like Complexes as Potent Anticancer Agents
por: Ghanbari, Zahra, et al.
Publicado: (2014)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
por: Cai, Xiaoxia, et al.
Publicado: (2019)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Magnetic interactions and in vitro study of biocompatible hydrocaffeic acid-stabilized Fe–Pt clusters as MRI contrast agents
por: Kostevšek, N., et al.
Publicado: (2018)

GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
por: Pu, Fan, et al.
Publicado: (2015)

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
por: Thian, Yee Liang, et al.
Publicado: (2013)

Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging
por: Fox, Matthew S., et al.
Publicado: (2016)

MRI contrast agents: from molecules to particles
por: Laurent, Sophie, et al.
Publicado: (2017)

Correction to: Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qmqprrj6op0g71pg5ibq4er2gk